Search

Your search keyword '"Miah,Saiful"' showing total 300 results
Start Over Author "Miah,Saiful"
300 results on '"Miah,Saiful"'

3. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience

Author

Reddy, Deepika, Peters, Max, Shah, Taimur T., van Son, Marieke, Tanaka, Mariana Bertoncelli, Huber, Philipp M., Lomas, Derek, Rakauskas, Arnas, Miah, Saiful, Eldred-Evans, David, Guillaumier, Stephanie, Hosking-Jervis, Feargus, Engle, Ryan, Dudderidge, Tim, Hindley, Richard G., Emara, Amr, Nigam, Raj, McCartan, Neil, Valerio, Massimo, Afzal, Naveed, Lewi, Henry, Orczyk, Clement, Ogden, Chris, Shergill, Iqbal, Persad, Raj, Virdi, Jaspal, Moore, Caroline M., Arya, Manit, Winkler, Mathias, Emberton, Mark, and Ahmed, Hashim U.

Published
2022
Full Text
View/download PDF

4. The “Is mpMRI Enough” or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy

Author

Stonier, Thomas, Simson, Nick, Shah, Taimur, Lobo, Niyati, Amer, Tarik, Lee, Su-Min, Bass, Edward, Chau, Edwin, Grey, Alistair, McCartan, Neil, Acher, Peter, Ahmad, Imran, Arumainayagam, Nimalan, Brown, Dominic, Chapman, Alex, Elf, Deborah, Hartington, Thomas, Ibrahim, Ibrahim, Leung, Hing, Liyanage, Sidath, Lovegrove, Catherine, Malthouse, Theo, Mateen, Bilal, Mistry, Kiki, Morrison, Iain, Nalagatla, Sarika, Persad, Raj, Pope, Alvan, Sokhi, Heminder, Syed, Hira, Tadtayev, Sergey, Tharmaratnam, Meera, Qteishat, Ahmed, Miah, Saiful, Emberton, Mark, Moore, Caroline, Walton, Tom, Eddy, Ben, and Ahmed, Hashim U.

Published
2021
Full Text
View/download PDF

7. Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study

Author

Shah, Taimur T., Reddy, Deepika, Peters, Max, Ball, Daniel, Kim, Na Hyun, Gomez, Enrique Gomez, Miah, Saiful, Evans, David Eldred, Guillaumier, Stephanie, van Rossum, Peter S. N., Van Son, Marieke J., Hosking-Jervis, Feargus, Dudderidge, Tim, Hindley, Richard, Emara, Amr, McCracken, Stuart, Greene, Damian, Nigam, Raj, McCartan, Neil, Valerio, Massimo, Minhas, Suks, Afzal, Naveed, Lewi, Henry, Ogden, Chris, Persad, Raj, Virdi, Jaspal, Moore, Caroline M., Arya, Manit, Emberton, Mark, Ahmed, Hashim U., and Winkler, Mathias

Published
2021
Full Text
View/download PDF

10. A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk

Author

Miah, Saiful, Hosking-Jervis, Feargus, Connor, Martin J., Eldred-Evans, David, Shah, Taimur T., Arya, Manit, Barber, Neil, Bhardwa, Jeetesh, Bott, Simon, Burke, Daniel, Doherty, Alan, Foster, Christopher, Freeman, Alex, Hindley, Richard, Jameson, Charles, Karim, Omer, Laniado, Marc, Montgomery, Bruce, Nigam, Raj, Punwani, Shonit, Sinclair, Andrew, Winkler, Mathias, Allen, Clare, and Ahmed, Hashim U.

Published
2020
Full Text
View/download PDF

13. Investigation into the role of MicroRNA in bladder cancer

Author

Miah, Saiful and Catto, James

Subjects
610
Abstract

Background: Urothelial bladder cancer is a common disease that arises by at least two different molecular pathways. The biology of bladder cancer is incompletely understood, making the management of patients with this disease difficult. Recent evidence implicates a regulatory role for microRNA in cancer, suggesting the need to study these in more depth. In this thesis I will focus upon these RNAs to better understand their role in bladder cancer. Firstly, I hypothesise that altered microRNA expression contributes to bladder cancer carcinogenesis. Secondly, I will focus upon the use of microRNA in the diagnosis of bladder cancer. Urinary biomarkers are needed to improve the care and reduce the cost of managing bladder cancer. Current biomarkers struggle to identify both high and low-grade cancers due to differing molecular pathways. Therefore, my second hypothesis is that urinary microRNAs reflecting low and high-grade pathways could detect a broad spectrum of bladder cancers to overcome differences in genetic events seen within the disease. Thirdly, I will manipulate the expression of microRNA-1224-3p in urothelial cells and assess the phenotypical outcomes. Current chemotherapeutic regimes in bladder cancer are limited with no gene-based agents in the near horizon. My third hypothesis is that the manipulation of microRNA will alter urothelial cells in an anti-tumourigenic manner. Materials and Methods: To test the first hypothesis, I examined the expression of 322 microRNAs in 78 normal and malignant urothelial samples using real-time rtPCR. To test the second hypothesis, I investigated urinary samples from patients with bladder cancer (n=68) and age-matched controls (n=53) which included patients with a diagnosis of urosepsis (n=6). Fifteen microRNAs were quantified using real-time PCR from these urine samples. To test the third hypothesis, I investigated the under- and over-expression of microRNA-1224-3p on urothelial cells and investigated the phenotypical responses of these cells to microRNA manipulation. Results: Altered microRNA expression is common in bladder cancer, and changes occurs early in tumourogenesis. In normal urothelium from patients with bladder cancer, 11% of microRNA’s have altered expression when compared to disease-free controls. In bladder cancer microRNA alterations occur in a tumor phenotype-specific manner and can predict disease progression. High-grade UCC were characterized by microRNA up-regulation, including microRNA-21 that suppresses p53 function. In low-grade UCC there was down-regulation of many microRNA molecules including miR-99a/100 that regulate FGFR3 and FOXA1. MicroRNA expression is stable within urinary samples despite adverse handling. MicroRNA had the ability to be detected in urine after they were stored at room temperature for 48 hours. We detected differential expression of 10 microRNAs from patients with cancer and controls (miRs-15a/15b/24-1/27b/100/135b/203/212/328/1224-3p, ANOVA p<0.05). Individually, miR-1224-3p had the best individual performance with specificity, positive and negative predictive values and concordance of 83%, 83%, 75% and 77%, respectively. The combination of miRs-135b/15b/1224-3p detected bladder cancer with a high sensitivity (94.1%), sufficient specificity (51%) and was correct in 86% of patients (concordance). Over-expression of microRNA-1224-3p on urothelial cells was shown to be of a reproducible manner. Over-expression of microRNA-1224-3p resulted in a significant decrease of urothelial cell viability. Conclusion: This was one of the first studies to demonstrate that distinct microRNA alterations characterise bladder cancer in a grade-specific manner. These data reveal new insights into disease biology and have implications regarding tumor diagnosis, prognosis and therapy. The use of the panel of urinary microRNAs-135b/15b/1224-3p in patients with haematuria would have identified 94% of bladder cancers, whilst reducing cystoscopy rates by 26%. However, 2 invasive cancers (3%) would have been missed. Over-expression of microRNA-1224-3p leads to the inhibition of urothelial cell growth and viability. With further studies, this finding could potentially be developed to create a chemotherapeutic agent for patients with bladder cancer.

Published
2014

15. 10 top tips to be a good robotic assistant

Author

Bissala, Roland Pika, primary, Mercader, Claudia, additional, Raslan, Mutie, additional, Campbell, Matt, additional, López, Francisco, additional, Leslie, Tom, additional, Miah, Saiful, additional, Bell, Richard, additional, Hamdy, Freddie, additional, and Lamb, Alastair, additional

Published
2023
Full Text
View/download PDF

18. MP73-11 MEDIUM TERM OUTCOMES FOLLOWING PRIMARY FOCAL CRYOTHERAPY FOR LOCALISED PROSTATE CANCER IN 323 PATIENTS, A MULTI-INSTITUTIONAL OBSERVATIONAL STUDY OVER 10 YEARS

Author

Reddy, Deepika, primary, Peters, Max, additional, Van Son, Marieke, additional, Tanaka, Mariana Bertoncelli, additional, Huber, Philipp, additional, Lomas, Derek, additional, Rakauskas, Arnas, additional, Miah, Saiful, additional, Eldred-Evans, David, additional, Cullen, Emma, additional, Dudderidge, Tim, additional, McCracken, Stuart, additional, Greene, Damian, additional, Nigam, Raj, additional, McCartan, Neil, additional, Valerio, Massimo, additional, Orczyk, Clement, additional, Virdi, Jaspal, additional, Arya, Manit, additional, Shah, Taimur, additional, and Ahmed, Hashim, additional

Published
2023
Full Text
View/download PDF

19. Suppl Figures 1-8 from Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA

Author

Drayton, Ross M., primary, Rehman, Ishtiaq, primary, Clarke, Raymond, primary, Zhao, Zhongming, primary, Pang, Karl, primary, Miah, Saiful, primary, Stoehr, Robert, primary, Hartmann, Arndt, primary, Blizard, Sheila, primary, Lavin, Martin, primary, Bryant, Helen E., primary, Martens-Uzunova, Elena S., primary, Jenster, Guido, primary, Hamdy, Freddie C., primary, Gardiner, Robert A., primary, and Catto, James W.F., primary

Published
2023
Full Text
View/download PDF

20. Suppl. Tables 1-3 from Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA

Author

Drayton, Ross M., primary, Rehman, Ishtiaq, primary, Clarke, Raymond, primary, Zhao, Zhongming, primary, Pang, Karl, primary, Miah, Saiful, primary, Stoehr, Robert, primary, Hartmann, Arndt, primary, Blizard, Sheila, primary, Lavin, Martin, primary, Bryant, Helen E., primary, Martens-Uzunova, Elena S., primary, Jenster, Guido, primary, Hamdy, Freddie C., primary, Gardiner, Robert A., primary, and Catto, James W.F., primary

Published
2023
Full Text
View/download PDF

22. Suppl Figure legends from Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA

Author

Drayton, Ross M., primary, Rehman, Ishtiaq, primary, Clarke, Raymond, primary, Zhao, Zhongming, primary, Pang, Karl, primary, Miah, Saiful, primary, Stoehr, Robert, primary, Hartmann, Arndt, primary, Blizard, Sheila, primary, Lavin, Martin, primary, Bryant, Helen E., primary, Martens-Uzunova, Elena S., primary, Jenster, Guido, primary, Hamdy, Freddie C., primary, Gardiner, Robert A., primary, and Catto, James W.F., primary

Published
2023
Full Text
View/download PDF

23. Data from Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

Author

Catto, James W.F., primary, Miah, Saiful, primary, Owen, Helen C., primary, Bryant, Helen, primary, Myers, Katie, primary, Dudziec, Ewa, primary, Larré, Stéphane, primary, Milo, Marta, primary, Rehman, Ishtiaq, primary, Rosario, Derek J., primary, Di Martino, Erica, primary, Knowles, Margaret A., primary, Meuth, Mark, primary, Harris, Adrian L., primary, and Hamdy, Freddie C., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Materials, Figures 1-5, Tables 1-2 from Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

Author

Catto, James W.F., primary, Miah, Saiful, primary, Owen, Helen C., primary, Bryant, Helen, primary, Myers, Katie, primary, Dudziec, Ewa, primary, Larré, Stéphane, primary, Milo, Marta, primary, Rehman, Ishtiaq, primary, Rosario, Derek J., primary, Di Martino, Erica, primary, Knowles, Margaret A., primary, Meuth, Mark, primary, Harris, Adrian L., primary, and Hamdy, Freddie C., primary

Published
2023
Full Text
View/download PDF

25. The use of artificial intelligence and deep learning reconstruction in urological computed tomography: Dose reduction at ghost level.

Author

Rauf, Abdul, Javed, Saqib, Chandrasekar, Bhargavi, Miah, Saiful, Lyttle, Margaret, Siraj, Mamoon, Mukherjee, Rono, McLeavy, Christopher, Alaaraj, Hazem, and Hawkins, Richard

Subjects
ARTIFICIAL intelligence, DEEP learning, COMPUTED tomography, URINARY calculi, URINARY organs, DICOM (Computer network protocol)
Abstract

Objective: The objective of the study is to demonstrate that with the use of artificial intelligence (AI) in computed tomography (CT), radiation doses of CT kidney-ureter-bladder (KUB) and CT urogram (CTU) can be reduced to less than that of X-ray KUB and CT KUB, respectively, while maintaining the good image quality. Materials and Methods: We reviewed all CT KUBs (n = 121) performed in September 2019 and all CTUs (n = 74) performed in December 2019 at our institution. The dose length product (DLP) of all CT KUBs and each individual phase of CTU were recorded. DLP of each scan done with new scanner (Canon Aquilion One Genesis with AiCE [CAOG]) which uses AI and deep learning reconstruction (DLR) were compared against traditional non-AI scanner (GE OPTIMA 660 [GEO-660]). We also compared DLPs of both scanners against the United Kingdom, National Diagnostic Reference Levels (NDRL) for CT. Results: One hundred and twenty-one patient's CT KUBs and 74 patient's CTUs were reviewed. For CT KUB group, the mean DLP of 81/121 scans done using AI/DLR scanner (CAOG) was 77.8 mGy cm (1.16 mSv), while the mean DLP of 40/121 CT KUB done with GEO-660 was 317.1 mGy cm (4.75 mSv). For CTU group, the mean DLP for 46/74 scans done using AI/DLR scanner (CAOG) was 401.9 mGy cm (6 mSv), compared to mean DLP of 1352.6 mGy cm (20.2 mSv) from GEO-660. Conclusion: We propose that CT scanners using AI/DLR method have the potential of reducing radiation doses of CT KUB and CTU to such an extent that it heralds the extinction of plain film XR KUB for follow-up of urinary tract stones. To the best of our knowledge, this is the first study comparing CT KUB and CTU doses from new scanners utilizing AI/DLR technology with traditional scanners using hybrid iterative reconstruction technology. Moreover, we have shown that this technology can markedly reduce the cumulative radiation burden in all urological patients undergoing CT examinations, whether this is CT KUB or CTU. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

27. Testosterone Replacement Therapy in the Aged Male: Monitoring Patients’ Quality of Life Utilizing Scoring Systems

Author

Tsampoukas,Georgios, Pang,Karl H, Papatsoris,Athanasios, Moussa,Mohamad, and Miah,Saiful

Subjects
International Journal of General Medicine
Abstract

Georgios Tsampoukas,1,2 Karl H Pang,3 Athanasios Papatsoris,2,4 Mohamad Moussa,5 Saiful Miah6 1Department of Urology, The Great Western Hospital, Swindon, UK; 2U-merge Scientific Office, Athens, Greece; 3Institute of Andrology, University College London Hospital, London, UK; 4Department of Urology, Sismanoglio University Hospital of Athens, Athens, Greece; 5Al Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon; 6Department of Urology, Wycombe Hospital, Buckinghamshire NHS Trust, High Wycombe, UKCorrespondence: Georgios Tsampoukas, Department of Urology, The Great Western Hospital, Swindon, UK, Email tsampoukasg@gmail.comAbstract: Hypogonadism has been associated with significant deterioration of well-being. In the aging male, late-onset hypogonadism affects sexual life, mental health, levels of energy, lower urinary tract symptoms and, therefore, quality of life may be found significantly deteriorated. Testosterone replacement or supplementation therapy has been found efficient to reverse the adverse effects of hypogonadism and improve quality of life. Scales and questionnaires assessing the general health, urinary symptoms, sexual health, and cognition can provide a thorough assessment of the clinical syndrome, optimize treatment, assist the follow-up, and facilitate referrals to other specialties depending on the chief complaint. A systematic assessment might combine several tools, but the optimal ones and the exact usage is unknown. In this narrative review, we are flipping through the literature presenting the available tools per domain for the assessment of quality of life in men on testosterone replacement therapy and we discuss the optimal usage.Keywords: testosterone replacement treatment, quality of life, sexual health, well-being, mental health, lower urinary tract symptoms

Published
2022

28. MP55-01 CANCER CONTROL OUTCOMES FOLLOWING FOCAL THERAPY USING HIFU IN 1,379 MEN WITH NON-METASTATIC PROSTATE CANCER: A MULTI-INSTITUTE 15-YEAR EXPERIENCE

Author

Reddy, Deepika, primary, Peters, Max, additional, Shah, Taimur, additional, van Son, Marieke, additional, Bertoncelli, Mariana Tanaka, additional, Huber, Philipp, additional, Lomas, Derek, additional, Rakauskas, Arnas, additional, Miah, Saiful, additional, Eldred-Evans, David, additional, Guillaumier, Stephanie, additional, Hosking-Jervis, Feargus, additional, Engle, Ryan, additional, Dudderidge, Tim, additional, Hindley, Richard, additional, Emara, Amr, additional, Nigam, Raj, additional, McCartan, Neil, additional, Valerio, Massimo, additional, Afzal, Naveed, additional, Lewi, Henry, additional, Orczyk, Clement, additional, Ogden, Chris, additional, Shergill, Iqbal, additional, Persad, Raj, additional, Virdi, Jaspal, additional, Moore, Caroline, additional, Arya, Manit, additional, Winkler, Mathias, additional, Emberton, Mark, additional, and Ahmed, Hashim, additional

Published
2022
Full Text
View/download PDF

29. MP55-06 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: 6 YEAR ONCOLOGICAL AND SAFETY OUTCOMES

Author

Reddy, Deepika, primary, Peters, Max, additional, Shah, Taimur, additional, van Son, Marieke, additional, Bertoncelli, Mariana Tanaka, additional, Huber, Philipp, additional, Lomas, Derek, additional, Rakauskas, Arnas, additional, Miah, Saiful, additional, Eldred-Evans, David, additional, Guillaumier, Stephanie, additional, Hosking-Jervis, Feargus, additional, Engle, Ryan, additional, Dudderidge, Tim, additional, Hindley, Richard, additional, Emara, Amr, additional, Nigam, Raj, additional, McCartan, Neil, additional, Valerio, Massimo, additional, Afzal, Naveed, additional, Lewi, Henry, additional, Orczyk, Clement, additional, Ogden, Chris, additional, Shergill, Iqbal, additional, Persad, Raj, additional, Virdi, Jaspal, additional, McCracken, Stuart, additional, Greene, Damian, additional, Moore, Caroline, additional, Arya, Manit, additional, Winkler, Mathias, additional, Emberton, Mark, additional, and Ahmed, Hashim, additional

Published
2022
Full Text
View/download PDF

30. MP51-13 FLUORINE-18 (18F) PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITRON EMISSION TOMOGRAPHY (PET) AND THE DIAGNOSIS AND STAGING OF PRIMARY PROSTATE CANCER (PCA)

Author

Byrne, Matthew, primary, Ranasinha, Nithesh, additional, Mercader, Claudia, additional, Raslan, Mutie, additional, Lewis, Francesca, additional, Gorgoraptis, Stefanos, additional, Sathanapally, Ganesh, additional, Vieira, Ana Catarina Lopes, additional, Jedrzej, Golebka, additional, Peiris, Bryony, additional, Tuthill, Mark, additional, Protheroe, Andrew, additional, Camilleri, Philip, additional, Turner, Phil, additional, Andrade, Gerard, additional, Miah, Saiful, additional, Leslie, Tom, additional, Bryant, Richard, additional, Hamdy, Freddie, additional, MacPherson, Ruth, additional, Gleeson, Fergus, additional, and Lamb, Alastair D., additional

Published
2022
Full Text
View/download PDF

31. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience

Author

Arts-assistenten Radiotherapie, Onderzoek Radiotherapie, Reddy, Deepika, Peters, Max, Shah, Taimur T, van Son, Marieke, Tanaka, Mariana Bertoncelli, Huber, Philipp M, Lomas, Derek, Rakauskas, Arnas, Miah, Saiful, Eldred-Evans, David, Guillaumier, Stephanie, Hosking-Jervis, Feargus, Engle, Ryan, Dudderidge, Tim, Hindley, Richard G, Emara, Amr, Nigam, Raj, McCartan, Neil, Valerio, Massimo, Afzal, Naveed, Lewi, Henry, Orczyk, Clement, Ogden, Chris, Shergill, Iqbal, Persad, Raj, Virdi, Jaspal, Moore, Caroline M, Arya, Manit, Winkler, Mathias, Emberton, Mark, Ahmed, Hashim U, Arts-assistenten Radiotherapie, Onderzoek Radiotherapie, Reddy, Deepika, Peters, Max, Shah, Taimur T, van Son, Marieke, Tanaka, Mariana Bertoncelli, Huber, Philipp M, Lomas, Derek, Rakauskas, Arnas, Miah, Saiful, Eldred-Evans, David, Guillaumier, Stephanie, Hosking-Jervis, Feargus, Engle, Ryan, Dudderidge, Tim, Hindley, Richard G, Emara, Amr, Nigam, Raj, McCartan, Neil, Valerio, Massimo, Afzal, Naveed, Lewi, Henry, Orczyk, Clement, Ogden, Chris, Shergill, Iqbal, Persad, Raj, Virdi, Jaspal, Moore, Caroline M, Arya, Manit, Winkler, Mathias, Emberton, Mark, and Ahmed, Hashim U

Published
2022

32. New recommendations to reduce unnecessary blood tests after robot‐assisted radical prostatectomy

Author

Nathan, Arjun, Hanna, Nancy, Rashid, Amir, Patel, Sonam, Phuah, Yuzhi, Flora, Kiran, Fricker, Monty, Cleaveland, Paul, Kasivisvanathan, Veeru, Williams, Norman, Miah, Saiful, Collins, Justin, Kelkar, Anand, Sridhar, Ashwin, Hines, John, Briggs, Tim, Kelly, John, Shah, Nimish, Shaw, Greg, Sooriakumaran, Prasanna, Rajan, Prabhakar, Lamb, Benjamin W., and Nathan, Senthil

Published
2021

35. Protocol for 18F-PSMA PET imaging in staging and management of prostate cancer - a retrospective cohort study

Author

Byrne, Matthew H V, primary, Ranasinha, Nithesh, additional, Bryant, Richard J, additional, Hamdy, Freddie C, additional, Leslie, Tom, additional, Miah, Saiful, additional, Gleeson, Fergus, additional, MacPherson, Ruth, additional, Tuthill, Mark, additional, Protheroe, Andy, additional, Turner, Phil, additional, Sabharwal, Ami, additional, Andrade, Gerard, additional, and Lamb, Alastair D, additional

Published
2021
Full Text
View/download PDF

38. New recommendations to reduce unnecessary blood tests after robot‐assisted radical prostatectomy

Author

Nathan, Arjun, primary, Hanna, Nancy, additional, Rashid, Amir, additional, Patel, Sonam, additional, Phuah, Yuzhi, additional, Flora, Kiran, additional, Fricker, Monty, additional, Cleaveland, Paul, additional, Kasivisvanathan, Veeru, additional, Williams, Norman, additional, Miah, Saiful, additional, Collins, Justin, additional, Kelkar, Anand, additional, Sridhar, Ashwin, additional, Hines, John, additional, Briggs, Tim, additional, Kelly, John, additional, Shah, Nimish, additional, Shaw, Greg, additional, Sooriakumaran, Prasanna, additional, Rajan, Prabhakar, additional, Lamb, Benjamin W, additional, and Nathan, Senthil, additional

Published
2021
Full Text
View/download PDF

39. Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study

Author

Arts-assistenten Radiotherapie, Cancer, Onderzoek Radiotherapie, Shah, Taimur T, Reddy, Deepika, Peters, Max, Ball, Daniel, Kim, Na Hyun, Gomez, Enrique Gomez, Miah, Saiful, Evans, David Eldred, Guillaumier, Stephanie, van Rossum, Peter S N, Van Son, Marieke J, Hosking-Jervis, Feargus, Dudderidge, Tim, Hindley, Richard, Emara, Amr, McCracken, Stuart, Greene, Damian, Nigam, Raj, McCartan, Neil, Valerio, Massimo, Minhas, Suks, Afzal, Naveed, Lewi, Henry, Ogden, Chris, Persad, Raj, Virdi, Jaspal, Moore, Caroline M, Arya, Manit, Emberton, Mark, Ahmed, Hashim U, Winkler, Mathias, Arts-assistenten Radiotherapie, Cancer, Onderzoek Radiotherapie, Shah, Taimur T, Reddy, Deepika, Peters, Max, Ball, Daniel, Kim, Na Hyun, Gomez, Enrique Gomez, Miah, Saiful, Evans, David Eldred, Guillaumier, Stephanie, van Rossum, Peter S N, Van Son, Marieke J, Hosking-Jervis, Feargus, Dudderidge, Tim, Hindley, Richard, Emara, Amr, McCracken, Stuart, Greene, Damian, Nigam, Raj, McCartan, Neil, Valerio, Massimo, Minhas, Suks, Afzal, Naveed, Lewi, Henry, Ogden, Chris, Persad, Raj, Virdi, Jaspal, Moore, Caroline M, Arya, Manit, Emberton, Mark, Ahmed, Hashim U, and Winkler, Mathias

Published
2021

42. Publication Component of the UK Foundation Programme Application: Perception of Medical Students

Author

Pang, Karl H, Hobbis, Chloe, Burleigh, Eleanor J, and Miah, Saiful

Subjects
publication pressure, medical students, Advances in Medical Education and Practice, foundation school, UK postgraduate training, Original Research, foundation programme
Abstract

Karl H Pang,1 Chloe Hobbis,2 Eleanor J Burleigh,3 Saiful Miah4 1Department of Oncology and Metabolism, Academic Urology Unit, University of Sheffield, Sheffield, UK; 2Medical School, University of Sheffield, Sheffield, UK; 3Leeds Children Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK; 4Department of Urology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UKCorrespondence: Karl H PangDepartment of Oncology and Metabolism, Academic Urology Unit, University of Sheffield, Sheffield, UKEmail karlpang@doctors.org.ukIntroduction: The 2-year UK foundation programme (FP) application is based on a scoring system and final year medical students are ranked and allocated to their preferred choice of region to work and train in based on their scores following graduation. Points are allocated to academic components including publications. We aim to evaluate UK medical students’ perception of the publication component of the application.Methods: A 15-item online survey based on students’ perception of the publication component of the FP application was distributed to final year medical students from all UK medical schools. Opinions were sought via a 5-point Likert scale.Results: A total of 155 final year medical students from 9 medical schools completed the survey (response rate 155/1926, 8.05%). In the survey, 69.7% of students felt under pressure to achieve PubMed-indexed (PMI) publications, 7.1% were not aware that the FP application included points for PMI publications and 72.9% had no publications at the time of application. The main reasons for publishing were for the FP application (81.3% agreed) and to increase competitiveness for future specialty training (85.0% agreed). In contrast, 27.1% agreed that they were motivated to publish due to disseminating knowledge; 22.6% and 25.8% agreed that their medical school did not provide adequate training or opportunities for them to achieve PMI publications, respectively.Conclusion: The majority of students felt under pressure to publish with their primary motivation cited as enhancing their FP application. Overall training and opportunities to publish appear to be inadequate amongst the cohort studied. Medical schools should consider providing academic training and opportunities early to highlight the importance and rationale behind research/audits, minimise pressure and optimise research outputs in preparation for FP application.Keywords: foundation school, foundation programme, medical students, publication pressure, UK postgraduate training

Published
2020

43. Publication Component of the UK Foundation Programme Application: Perception of Medical Students

Author

Pang,Karl H, Hobbis,Chloe, Burleigh,Eleanor J, Miah,Saiful, Pang,Karl H, Hobbis,Chloe, Burleigh,Eleanor J, and Miah,Saiful

Abstract

Karl H Pang,1 Chloe Hobbis,2 Eleanor J Burleigh,3 Saiful Miah4 1Department of Oncology and Metabolism, Academic Urology Unit, University of Sheffield, Sheffield, UK; 2Medical School, University of Sheffield, Sheffield, UK; 3Leeds Children Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK; 4Department of Urology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UKCorrespondence: Karl H PangDepartment of Oncology and Metabolism, Academic Urology Unit, University of Sheffield, Sheffield, UKEmail karlpang@doctors.org.ukIntroduction: The 2-year UK foundation programme (FP) application is based on a scoring system and final year medical students are ranked and allocated to their preferred choice of region to work and train in based on their scores following graduation. Points are allocated to academic components including publications. We aim to evaluate UK medical students’ perception of the publication component of the application.Methods: A 15-item online survey based on students’ perception of the publication component of the FP application was distributed to final year medical students from all UK medical schools. Opinions were sought via a 5-point Likert scale.Results: A total of 155 final year medical students from 9 medical schools completed the survey (response rate 155/1926, 8.05%). In the survey, 69.7% of students felt under pressure to achieve PubMed-indexed (PMI) publications, 7.1% were not aware that the FP application included points for PMI publications and 72.9% had no publications at the time of application. The main reasons for publishing were for the FP application (81.3% agreed) and to increase competitiveness for future specialty training (85.0% agreed). In contrast, 27.1% agreed that they were motivated to publish due to disseminating knowledge; 22.6% and 25.8% agreed that their medical school did not provide adequate training or opportunities for them to achieve PMI publications, respe

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results